131 related articles for article (PubMed ID: 3084307)
1. [Effects of transient or occult hyperprolactinemia on luteal function].
Aisaka K; Ando S; Kokubo K; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):117-25. PubMed ID: 3084307
[TBL] [Abstract][Full Text] [Related]
2. [Studies on prolactin secreting capacity in the ovulatory infertile patients with transient hyperprolactinemia].
Aisaka K; Ando S; Kokubo K; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1986 May; 62(5):662-71. PubMed ID: 3089848
[TBL] [Abstract][Full Text] [Related]
3. [Role of TRH or metoclopramide loading test in the diagnosis of so-called occult or latent hyperprolactinemia].
Aisaka K; Ando S; Kokuho K; Kaneda S; Tawada T; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):853-61. PubMed ID: 3119381
[TBL] [Abstract][Full Text] [Related]
4. [A study on pathogenesis and treatment of normoprolactinemic galactorrhea syndrome].
Aisaka K; Ando S; Kokubo K; Sasaki S; Sudo I; Toriya Y; Yoshida K; Mori H
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2385-92. PubMed ID: 4078422
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hyperprolactinemic luteal insufficiency with bromocriptine.
Andersen AN; Larsen JF; Eskildsen PC; Knoth M; Micic S; Svenstrup B; Nielsen J
Acta Obstet Gynecol Scand; 1979; 58(4):379-83. PubMed ID: 525272
[TBL] [Abstract][Full Text] [Related]
6. [The effects of dopamine agonist (bromocriptine) on the secretion of pituitary gonadotropins and ovarian sex steroids in normally cycling women].
Aisaka K; Mori H; Ogawa T; Kigawa T
Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1067-79. PubMed ID: 6440815
[TBL] [Abstract][Full Text] [Related]
7. Effect of luteal metoclopramide-induced hyperprolactinemia on pituitary and luteal responsiveness to gonadotropin-releasing hormone.
Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S
Horm Res; 1989; 31(4):169-74. PubMed ID: 2507435
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine therapy of luteal insufficiency accompanied with hyperprolactinemia in the follicular phase.
Kano T; Nishikawa K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):975-80. PubMed ID: 6875348
[TBL] [Abstract][Full Text] [Related]
9. Hyperprolactinemia in cases of infertility and amenorrhea.
Furuhjelm M; Rydner T; Carlström K
Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290
[TBL] [Abstract][Full Text] [Related]
10. [A study with diagnostic standard of occult hyperprolactinemia (OHP) and the effect of bromocriptine administration].
Aisaka K; Kaneda S; Tsuzuki H; Toriya Y; Kokuho K; Tamechika S; Saitoh H; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1993 Oct; 69(9):1017-27. PubMed ID: 8262272
[TBL] [Abstract][Full Text] [Related]
11. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
[TBL] [Abstract][Full Text] [Related]
12. Effects of nocturnal hyperprolactinemia on ovarian luteal function and galactorrhea.
Yamaguchi M; Aono T; Koike K; Nishikawa Y; Ikegami H; Miyake A; Tanizawa O
Eur J Obstet Gynecol Reprod Biol; 1991 May; 39(3):187-91. PubMed ID: 2032589
[TBL] [Abstract][Full Text] [Related]
13. Serum gonadotrophin and sex steroid hormone levels during mid-follicular and mid-luteal phases in hyperprolactinaemic women with regular menstrual cycles.
Nakano R
Br J Obstet Gynaecol; 1987 Feb; 94(2):142-6. PubMed ID: 3103671
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between luteal function and prolactin in infertile women with endometriosis].
Hayashi N; Taketani Y; Mizuno M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1720-4. PubMed ID: 2512358
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of the prolactin secreting capacity for the diagnosis of occult hyperprolactinemia].
Matsuoka R; Mori H; Tomonari R; Chen SZ; Kigawa T; Aisaka K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):586-90. PubMed ID: 3108420
[TBL] [Abstract][Full Text] [Related]
16. Luteal phase hyperprolactinemia.
Falk RJ; Anderson L
Int J Fertil Menopausal Stud; 1994; 39(5):272-7. PubMed ID: 7820160
[TBL] [Abstract][Full Text] [Related]
17. Analysis of clinical backgrounds and pathogenesis of luteal-phase defect.
Aisaka K; Yoshida K; Mori H
Horm Res; 1992; 37 Suppl 1():41-7. PubMed ID: 1427628
[TBL] [Abstract][Full Text] [Related]
18. The role of prolactin in luteal inadequacy: treatment of hyperprolactinaemia with bromocriptine.
Atasü T; Kösebay D; Aksu F
Curr Med Res Opin; 1988; 11(1):56-63. PubMed ID: 3383612
[TBL] [Abstract][Full Text] [Related]
19. Effects of an LH-releasing hormone antagonist on the secretion of LH, FSH, prolactin and ovarian steroids at different stages of the luteal phase in the stumptailed macaque (Macaca arctoides).
Fraser HM; Abbott M; Laird NC; McNeilly AS; Nestor JJ; Vickery BH
J Endocrinol; 1986 Oct; 111(1):83-90. PubMed ID: 3097236
[TBL] [Abstract][Full Text] [Related]
20. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
